Third approval in China for AstraZeneca and Daiichi Sankyo’s Enhertu in less than two years
The campaign targets 63 endemic districts across Bihar, Jharkhand, Karnataka, Odisha, Telangana, and Uttar Pradesh
Our centers are performing as expected or even better
The International Society of Aesthetic Plastic Surgery reported that non-surgical procedures outnumbered surgical ones globally in 2020
Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme
Lonza Bend (US) upgrades capabilities in early phase clinical manufacturing services with the addition of bottling and labeling equipment
Both departments will be equipped with specialized professionals and state-of-the-art facilities ensuring the highest standards of care
Relonchem Limited has received Marketing Authorization for the product Levonorgestrel 1.5 mg Tablets from UK MHRA
The successful completion of the global Phase 3 trials paves the way to obtain marketing approval in the U.S. and EU
Divis Laboratories has reported total income of Rs. 2,197 crores during the period ended June 30, 2024
Subscribe To Our Newsletter & Stay Updated
